Heart Failure Clinical Trial

Safety and Effectiveness of Cardiac Resynchronization Therapy With Defibrillation

Summary

The purpose of this study was to determine if cardiac resynchronization therapy when combined with defibrillation is safe and effective in the treatment of symptomatic heart failure.

View Full Description

Full Description

Patients enrolled received a device with cardiac resynchronization therapy (CRT) and defibrillation. Patients were randomized to CRT on or off for up to six months and evaluated for mortality, hospitalization, and functional outcomes including exercise capacity, quality of life, symptomatic status, and echocardiographic analysis.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Symptomatic heart failure
Left ventricular ejection fraction <= 35%
QRS width >= 120 ms
Indicated for an implantable cardioverter defibrillator

Exclusion Criteria:

Indicated for a pacemaker
Atrial tachyarrhythmias

Study is for people with:

Heart Failure

Phase:

Phase 2

Estimated Enrollment:

581

Study ID:

NCT00387803

Recruitment Status:

Completed

Sponsor:

Boston Scientific Corporation

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Multiple locations
Saint Paul Minnesota, 55112, United States

How clear is this clinincal trial information?

Study is for people with:

Heart Failure

Phase:

Phase 2

Estimated Enrollment:

581

Study ID:

NCT00387803

Recruitment Status:

Completed

Sponsor:


Boston Scientific Corporation

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider